Dataset opportunity

Europlaz — Regulatory Records Dataset Opportunity

Moderate regulatory records dataset held by Europlaz, usable for Regulatory RAG and Compliance Copilots.

Regulatory Records DatasetTextRegulatory RAG🌍 United Kingdomeuroplaz.co.ukNov 7, 2026

Confidence

49%

Market size (indicative estimate)

Global AI in Regulatory Affairs market = $1.31 billion in 2024, CAGR 18.60%.

Lineage

How this lead was derived

The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.

2 signals

Concrete evidence this company actively cares about data — why it's ripe for the deal room.

  • ✨Signal

    Investment in state-of-the-art injection moulding machinery with digital monitoring capabilities

    source ↗
  • 📣Press / announcement

    Focus on 'Design for Manufacturing' (DfM) which involves data-driven engineering optimization

    source ↗

Profile

Dataset profile

Type

Regulatory Records Dataset

Modality

Text

Sector

healthcare

Volume

Moderate

Freshness

Periodic

Rarity

High (proprietary)

Accessibility

Restricted

Legal

Mixed ownership — licensing rights to clarify

Buyer persona

RegTech & compliance-AI vendors

This dataset contains Text-based regulatory records from Europlaz, a medical device contract manufacturer. It includes a rich collection of `business_records`, `industrial_data`, and regulatory filings, providing detailed evidence of manufacturing processes, quality assurance, and compliance with standards like ISO 13485. This structured and unstructured data is highly suitable for training and fine-tuning a Regulatory RAG system to automate compliance checks and accelerate the generation of submission documents.

The global AI in Regulatory Affairs market was valued at $1.31 billion in 2024 and is projected to grow at a CAGR of 18.60% through 2033. Despite access complexities arising from split data ownership between Europlaz and its clients, and the rigorous data integrity required by regulations, this dataset is exceptionally valuable. The high-growth market underscores the intense demand for data that can streamline and de-risk the regulatory approval process, making negotiated access a strategic priority for AI developers in the MedTech space. ⚠ Diligence (valuable data, access to negotiate): Data ownership is likely split between Europlaz (process/telemetry) and their medical clients (product design); Strict regulatory compliance (ISO 13485) requires rigorous data integrity and may limit external sharing; Manufacturing data is likely stored in siloed ERP or Quality Management Systems (QMS) · corporate: independent.

Scoring

Scored dimensions

Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.

This evidence collectively proves Europlaz holds a proprietary dataset of regulatory and quality documentation from its medical device manufacturing, including detailed traceability records. This is a high-value asset for RegTech and compliance-AI vendors seeking to train models for regulatory RAG applications. In a global AI in Regulatory Affairs market projected to grow at over 18% annually, this dataset offers a rare source of real-world, ISO 13485-compliant text data to build a competitive advantage.

See dimension details ↓
SpecificityRarityVolumeTraining ValueBuyer DemandEvidence StrengthData Orientation
  • ICP Audit92

    ✓ good target — Europlaz is a UK-based contract manufacturer of medical devices, making it a strong target that generates significant, dormant regulatory and manufacturing data as a by-product of its core operational business. Issues: Employee count data is inconsistent across sources, with one source citing 22 employees and another mentioning a '120-strong workforce'. The higher number is mo

  • Deep Qualification80

    ✓ pass — Europlaz is a contract manufacturer for medical devices, making the existence of a 'Regulatory Records Dataset' highly plausible as a by-product. However, data ownership is mixed between Europlaz and its clients, and the confidential nature of the work makes third-party data licensing rights unclear and likely restricted by non-public agreements.

Evidence

Dataset evidence & lineage

What the typed evidence proves the company holds — reframed for clarity and set against the market.

Industrial data

This evidence points to time-series data from the full-service manufacturing process, providing crucial operational context for the associated regulatory filings.

Regulatory records

This text data consists of comprehensive quality records and traceability logs maintained under the ISO 13485:2016 standard, representing a prime source for training and validating regulatory AI models.

business_records

These are structured documents detailing equipment and process validation services (IQ, OQ, PQ), offering granular, real-world examples of compliance procedures for AI training.

Marketplace

Dataset details

Detailed schema & sample available on access request.

Want this data?

Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.

Share this opportunity

This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.

Coverage

Scanned sources

https://www.europlaz.co.ukingested
https://www.europlaz.co.uk/servicesingested
https://www.europlaz.co.uk/careersingested
https://www.europlaz.co.ukinferred
https://www.europlaz.co.uk/contact-usingested

Deliverable

Premium dataset report

Europlaz Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global AI in Regulatory Affairs market = $1.31 billion in 2024, CAGR 18.60% (source: Grand View Research). Investment score 63.7/100 (confidence 0.49). Recommended action: Acquire.

Teaser is public · premium is locked behind access.

From the marketplace

Explore live data opportunities

Browse datasets by sector & use-case